Product Information
CIPROFLOXACIN HCL 250 MG TAB is a generic product labeled by Solco Healthcare US LLC, priced at $0.0842 per EA under NDC 43547068810. Its NADAC has been published 133 times since Dec 13, 2023.
Strength
250 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547068810
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208921On Market Since
10/1/2023
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN HCL 250 MG TAB has been published 133 times since Dec 13, 2023, and over the history we have for it it has declined 20.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0842 per EA |
|---|---|
| All-time high | $0.1058 (Dec 13, 2023) |
| All-time low | $0.0811 (Nov 20, 2024) |
| 52-week high | $0.0917 |
| 52-week low | $0.0842 |
| Median price | $0.0902 |
| Average price | $0.0922 |
| Largest weekly change | -21.4% (Apr 17, 2024) |
| Weeks tracked | 133 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Ciprofolxacin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN HCL 250 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN HCL 250 MG TAB, manufactured by Solco Healthcare US LLC, is $0.0842 per EA (NDC 43547068810), effective Jun 24, 2026.
How has the price of CIPROFLOXACIN HCL 250 MG TAB changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has declined 20.4%. It has been tracked across 133 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN HCL 250 MG TAB?
Since Dec 13, 2023, the NADAC for CIPROFLOXACIN HCL 250 MG TAB has ranged from a low of $0.0811 (Nov 20, 2024) to a high of $0.1058 (Dec 13, 2023), with a median of $0.0902 per EA.
Are there cheaper alternatives to CIPROFLOXACIN HCL 250 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CIPROFLOXACIN HCL 250 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures CIPROFLOXACIN HCL 250 MG TAB?
CIPROFLOXACIN HCL 250 MG TAB (NDC 43547068810) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification